Navigation Links
Martek Announces Fourth Quarter and FY 2007 Financial Results
Date:12/12/2007

Diluted earnings

per share $0.55 $0.00 $0.98 $0.46

Shares used in

computing basic

earnings per share 32,649,799 32,153,835 32,336,314 32,113,301

Shares used in

computing diluted

earnings per share 32,975,155 32,341,835 32,593,125 32,343,015

Unaudited Condensed Consolidated Balance Sheets Data

October 31, October 31,

2007 2006

Assets:

Cash, cash equivalents and short-term

investments $21,648 $26,828

Accounts receivable, net 41,643 32,746

Inventories, net 109,409 112,320

Other current assets 8,237 8,893

Property, plant and equipment, net 277,915 286,922

Deferred tax asset 51,306 42,800

Goodwill and other, net 86,537 87,464

Total assets $596,695 $597,973

Liabilities and stockholders' equity:

Current liabilities $46,141 $49,786

Non-current liabilities 18,827 55,612

Stockholders' equity 531,727 492,575

Total liabilities and stockholders' equity $596,695 $597,973

Unaudited Condensed Consolidated Cash Flow Data

Year ended October 31,

2007 2006

Operating activities:

Net income $32,013 $14,938

Non-cash items 31,70
'/>"/>

SOURCE Martek Biosciences Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Martek to Announce Third Quarter 2007 Results on September 5, 2007
2. Martek to Present at Upcoming UBS Conference
3. Martek Signs Multi-Year Worldwide Sole Source Supply Agreement with Abbott
4. Martek Announces Settlement of OmegaTech Milestone Litigation
5. Martek to Obtain Permanent Injunction Against Lonza in U.S. Patent Infringement Suit; Jury Verdict on Infringement of Two of Three Patents Upheld by Judge
6. European Patent Office Upholds Martek European DHA Food Patent; Scope of Original Claims Narrowed
7. Martek to Present at Upcoming ThinkEquity Partners Conference
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
10. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
11. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... ... June 30, 2015 , ... ... a webinar to provide advanced scientific research into new classes of Nanoscale Graphene-based ... energy. Touted as 'the wonder material of the 21st Century' by the ...
(Date:6/30/2015)... ... June 30, 2015 , ... With ... not sacrifice selectivity to achieve faster flow rates in comparison to nylon or ... significant open space to allow easy liquid flow while trapping particulates as small ...
(Date:6/30/2015)... N.Y. , June 30, 2015  Custom Computer ... announced today that they are silver sponsors of the ... official PCDC sponsor, Custom is lending their support of ... low-income communities. Since its founding in 1993, ... the primary care area.  PCDC has financed over 100 ...
(Date:6/30/2015)... Florida (PRWEB) , ... June 30, 2015 , ... ... cannabis digital media company, launched “Cannavoices,” an unprecedented digital video and broadcast ... largest but also the most dynamic collection of legal medical cannabis stories ever ...
Breaking Biology Technology:How Graphene–based Nanomaterials and Films Revolutionize Science Explained in July 9 Webinar Hosted by Park Systems 2How Graphene–based Nanomaterials and Films Revolutionize Science Explained in July 9 Webinar Hosted by Park Systems 3How Graphene–based Nanomaterials and Films Revolutionize Science Explained in July 9 Webinar Hosted by Park Systems 4New Nanofiber Membrane Provides Fast, Efficient Filtration 2Custom Computer Specialists Announces Sponsorship Of The Primary Care Development Corporation's Corporate Circle 2Cannavoices Launches a Legal Medical Cannabis Documentary Initiative 2Cannavoices Launches a Legal Medical Cannabis Documentary Initiative 3
... ViroPharma Incorporated (Nasdaq: VPHM ) ... transaction, $45 million principal amount or 18 percent ... 2017 for total consideration of approximately $21.2 million. ... million of principal debt are outstanding.As a result ...
... Patient Safety & Satisfaction Record ChallengeCORONA DEL MAR, ... Anesthesiologists (ASA) functions much like the American Medical ... Anesthesiology and JAMA , respectively) and ... Nonetheless, both groups function primarily (and legitimately) as ...
... 24, 2009, at 6:00 PM Central European Time/1:00 PM Eastern Time/10:00 ... MTA: CTIC) management team will host a Special Meeting in lieu ... at 501 Elliott Ave. West, Seattle, WA 98119. The meeting will ... archived for replay., ...
Cached Biology Technology:ViroPharma Improves Financial Position Through Repurchase of $45 Million Principal Amount of Senior Convertible Notes 2ViroPharma Improves Financial Position Through Repurchase of $45 Million Principal Amount of Senior Convertible Notes 3ViroPharma Improves Financial Position Through Repurchase of $45 Million Principal Amount of Senior Convertible Notes 4American Society of Anesthesiologists Primary Agenda Displayed Says Dr. Barry Friedberg of Cosmetic Surgery Anesthesia 2Cell Therapeutics, Inc. Special Meeting in Lieu of Annual Meeting of Shareholders Scheduled for Tuesday, March 24, 2009 2
(Date:6/24/2015)... The biologics safety testing market is growing ... market include growth of the pharmaceutical and biological industries ... the years, the number of drug approvals in North ... FDA approved 225 drug applications and Health Canada approved ... accounted for 3,822 of the pharmaceutical and ...
(Date:6/24/2015)... Switzerland , June 24, 2015 ... partnership with emerging biometric password solution one face ... one face in, entering ... a ground-breaking and affordable multifactor-authentication biometric answer to ... recognition technology, provided in partnership with KeyLemon, one ...
(Date:6/23/2015)... PALM BEACH GARDENS, Fla. , June ... of multi-factor identity management and authentication solutions, today ... Altus strong, multi-factor authentication solution.  The ... ease of use of the DigitalPersona Altus ... and biometric reader compatibility. In ...
Breaking Biology News(10 mins):Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4KeyLemon Announces Partnership With Biometric Password Solution onefacein 2Crossmatch Releases Enhanced DigitalPersona Altus Advanced Authentication Functionality 2
... 9 CBS Vision, the research division of CBS Corporation, and ... new research partnership that will allow OMD,s clients access to the ... in Las Vegas. , The new venture, which marries the ... will be called Communications Lab@OMD . , CBS,s Television City ...
... Spring Harbor, N.Y. Oncologists have had their hands ... have mutations that disable a protein called p53. As ... within cells. When cells lose p53, tumors grow aggressively ... might be tough, but they,re not invincible, suggests a ...
... The brilliance of butterfly wings has inspired a ... in the fields of security, energy and the environment. ... have just signed a collaborative contract to develop new ... Over the next three years a team of physicists ...
Cached Biology News:CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 2CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 3CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 4CSHL study shows that some malignant tumors can be shut down after all 2CSHL study shows that some malignant tumors can be shut down after all 3£3.2m ($5.4 million) research project to capture brilliance of butterfly wings 2
MagSi uniform silica particles coated with a carboxyl group containing polymer, covalently attached to the bead surface....
Mouse monoclonal [1241] to Parainfluenza Virus type 2...
... GenBank Accession Number : NM_002542 Immunogen ... corresponding to residues 166-223 of human AP-2α ... 0.1M Tris-glycine, pH 7.4, 0.15M NaCl, 0.05% ... to 30% Quality Assurance: routinely evaluated by ...
Rabbit Anti-Human Secretory Carrier Membrane Protein 2 (SCAMP2 Polyclonal AntibodyOther Sub-Family: not assigned-Other Applications: Western Blot...
Biology Products: